If you have been reading about Anti-doping and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-03-28. Numbers and descriptions here follow the published literature rather than marketing material.
Cardarine can be detected in biological samples and product materials using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The method separates compounds by chromatography and identifies them by mass-to-charge transitions, allowing low-level detection in urine or blood. Sample preparation often involves enzymatic hydrolysis, solid-phase extraction, or protein precipitation. Certified reference materials and isotope-labeled internal standards improve quantification. Detection windows depend on metabolism, matrix, and assay sensitivity, so no single universal window applies.
Regulatory treatment of cardarine differs by context and jurisdiction. In competitive sport, the World Anti-Doping Agency lists PPARδ agonists, including GW501516, as prohibited at all times. Outside sport, it lacks approval as a prescription medicine in major drug markets, and products sold for human consumption may be treated as unapproved drugs. Some countries also restrict importation or sale through general consumer protection and medicines laws. These classifications affect availability, testing, and legal risk without establishing therapeutic value.
Because cardarine is not an approved medicine, no pharmacopeial monograph defines its identity, purity, or storage requirements. Laboratories typically rely on in-house methods and reference standards when testing materials labeled as GW501516. Certificates of analysis may report purity and identity for a specific batch, but their scope varies and they do not guarantee safety or legal status. Independent verification can include high-performance liquid chromatography, mass spectrometry, nuclear magnetic resonance, and elemental analysis. The distinction between research chemical labeling and human use is significant because quality standards and oversight differ.
Stability of GW501516 depends on form, temperature, light exposure, and moisture. Solid reference material is typically stored frozen or refrigerated in a desiccator and protected from light. Solutions in organic solvents such as dimethyl sulfoxide are often kept frozen in aliquots to reduce freeze-thaw cycling. Aqueous solubility is low, so aqueous stock solutions can be difficult to prepare without cosolvents. Degradation may appear as changes in chromatographic purity or mass spectral signal. Stability studies are needed to establish shelf life for any specific preparation.
Quality assessment for cardarine samples usually combines identity, purity, and impurity testing. Nuclear magnetic resonance spectroscopy and mass spectrometry can confirm molecular structure, while high-performance liquid chromatography estimates purity. Certificates of analysis from testing laboratories may list these results, but they do not establish safety or legality. In the absence of approved manufacturing, products sold online may contain the wrong compound, variable amounts, or unlisted contaminants. Independent verification is therefore central to analytical work and to interpreting any reported biological activity.
| Property | Value | Notes |
|---|---|---|
| WADA classification | S4 Hormone and Metabolic Modulators | Prohibited at all times in sport. |
| Drug approval status | Not approved in major jurisdictions | No accepted therapeutic indication. |
| Common detection method | LC-MS/MS | Detects parent compound and metabolites. |
| Typical test matrix | Urine or blood | Urine is common in anti-doping testing. |
| Product labeling | Research chemical or supplement | Often not independently verified. |
Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.
Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.
A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.
Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.
Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.
== Medicinal uses == It is used to heal cuts and stop minor external bleeding in Fiji but its medicinal properties are still yet to be fully discovered. It is also a very popular local antiseptic medicine in Mizoram State of India, it is known locally as Japan Hlo. Its use has also been reported in the state of Arunachal Pradesh; fresh leaves are pounded and then applied over lacerations to stop bleeding and subsequent healing. In Bangladesh used to treat gastric ulcer and as a local antiseptic. The antioxidant activity and anthelmintic (anti-parasitic) activity of Mikania micrantha leaves has been studied.
21 April – Mark Menzies quits the Conservative Party and says he will stand down from Parliament at the next election. Robin Swann, who is the perspective Ulster Unionist candidate for South Antrim, announces he will step down from his post as Northern Ireland's Health Minister once the general election campaign begins. 22 April – Parliament passes the Safety of Rwanda Bill, with plans to deport the first asylum seekers to Kigali in July. Two men, including a parliamentary researcher, are charged with spying for China after providing information that could be "useful to an enemy". Conservative councillor Richard Solesbury-Timms, who represents Middleton Cheney on West Northamptonshire Council, leaves the party to sit as an independent citing the party's dealing with allegations against the council leader. 23 April – Patrick Harvie says he will resign as co-leader of the Scottish Greens if the party votes to end its coalition agreement with the SNP. Alliance Party MLA Patrick Brown resigns his South Down seat in the Northern Ireland Assembly, citing personal reasons for doing so. 24 April – Rishi Sunak vows to increase UK defence spending to 2.5% of GDP by 2030. Labour unveils its plans for improvements to train services, which include automatic refunds for delays, a "best price" guarantee and improved internet coverage. Jeffrey Donaldson appears at Newry Magistrates' Court to face charges of historic child abuse. Johnny Timpson, the UK's inaugural disability ambassador, resigns over the UK government's policy of clawing back benefit overpayment.
where a deuteron hitting uranium-238 produces two neutrons and neptunium-238, which decays by emitting negative beta particles to form plutonium-238. Plutonium-238 can also be produced by neutron irradiation of neptunium-237.
Like leptin, observations in both humans and animal models have shown that adiponectin is relevant to insulin sensitivity and energy homeostasis. In contrast, the relationship between resistin and adiposity is not consistent between rodent models and human subjects (See Peter Arner, 2005: "Resistin: yet another adipokine tells us that men are not mice"); hence, the notion of resistin as a genuine adipose-derived hormone remains questionable.
Sources: en.wikipedia.org
Ag+(aq) + 2 NH3(aq) ⇌ Ag(NH3)2+ AgCl(s) ⇌ Ag+(aq) + Cl−(aq) If these reactions both occurred in the same reaction vessel, the solubility of the silver chloride (AgCl) would be increased by the presence of NH3 because formation of the diammineargentum(I) complex (Ag(NH3)2+) consumes a significant portion of the free silver ions from the solution. By Le Chatelier's principle, this causes the equilibrium reaction for the dissolving of the silver chloride, which has silver ion as a product, to shift to the right. This new solubility can be calculated given the values of Kf and Ksp for the original reactions. The solubility is found essentially by combining the two separate equilibria into one combined equilibrium reaction and this combined reaction is the one that determines the new solubility. So Kc, the new solubility constant, is denoted by:
Thus, in the presence of the inhibitor, the enzyme's effective Km and Vmax become (α/α')Km and (1/α')Vmax, respectively. However, the modified Michaelis-Menten equation assumes that binding of the inhibitor to the enzyme has reached equilibrium, which may be a very slow process for inhibitors with sub-nanomolar dissociation constants. In these cases the inhibition becomes effectively irreversible, hence it is more practical to treat such tight-binding inhibitors as irreversible (see below). The effects of different types of reversible enzyme inhibitors on enzymatic activity can be visualised using graphical representations of the Michaelis–Menten equation, such as Lineweaver–Burk, Eadie-Hofstee or Hanes-Woolf plots. An illustration is provided by the three Lineweaver–Burk plots depicted in the Lineweaver–Burk diagrams figure. In the top diagram the competitive inhibition lines intersect on the y-axis, illustrating that such inhibitors do not affect Vmax. In the bottom diagram the non-competitive inhibition lines intersect on the x-axis, showing these inhibitors do not affect Km. However, since it can be difficult to estimate Ki and Ki' accurately from such plots, it is advisable to estimate these constants using more reliable nonlinear regression methods.
== Etymology == The area is named after the English town of Scarborough, inspired by Elizabeth Simcoe, the wife of John Graves Simcoe, the first lieutenant governor of Upper Canada. The bluffs along the Lake Ontario shores reminded her of the limestone cliffs in Scarborough, England. On August 4, 1793, she wrote in her diary, "The shore is extremely bold, and has the appearance of chalk cliffs, but I believe they are only white sand. They appeared so well that we talked of building a summer residence there and calling it Scarborough." Before that, the area was named Glasgow, after the Scottish city. The district acquired several nicknames due to its location and population. Following the creation of the Metropolitan Toronto, Scarberia, a portmanteau of Scarborough and Siberia, refers to Scarborough's further distance from Downtown Toronto and lower population density, in comparison to Etobicoke and North York. Until the extension of the Bloor-Danforth subway line into Scarborough, public transit connection between Scarborough and the rest of Toronto was limited and infrastructure investment from the municipal government and province of Ontario was low. In May 1988, Joyce Trimmer, who was campaigning to be mayor of the city of Scarborough, said, "The city of Scarborough needs strong leadership if it is to shed its 'Scarberia' image". Throughout the late 1990s, "Scarlem", a portmanteau of Scarborough and Harlem, became popular after an increase in gang violence in the area.
Sources: en.wikipedia.org
Anti-doping laboratories typically use LC-MS/MS to detect GW501516 and its metabolites in urine. The method is sensitive and can identify the compound at low concentrations. Detection depends on sample timing, metabolism, and the specific assay.
Legality varies by country and context. It lacks marketing approval as a medicine in major countries. Sports organizations prohibit its use at all times.
A certificate of analysis may report identity, purity, and testing methods for a specific batch. It does not guarantee safety or legal status. Independent verification can confirm whether the material matches the label.
LC-MS/MS is common, often after sample cleanup. The assay targets GW501516 or its metabolites.